Strategy. Evidence. Impact.
Strategic medical intelligence and advisory for teams facing the most complex decisions in oncology.
Our ExpertiseSTRATEGY
Medical and portfolio strategy that prioritises opportunities and drives long-term value.
EVIDENCE
Interpreting clinical and real-world evidence to inform trials, access, and positioning.
INTELLIGENCE
Competitive and landscape intelligence that anticipates change and informs action.
ADVISORY
Expert guidance across key decisions and pivotal inflections.
Partnership-first
Specialist expertise that strengthens teams.
FJScience works primarily through partnership — bringing senior oncology insights into medical education organisations, consultancies, and strategic teams who already serve pharmaceutical and biotech clients. We work alongside your team, not around it.
Twenty-six years at the centre of breast cancer’s most consequential developments.
Expertise in oncology
Deep therapeutic expertise.
Broader strategic perspective.
FJScience combines clinical understanding with competitive intelligence — helping you see around corners and make confident decisions in oncology.
Specialist focus in breast cancer with cross-tumour launch experience.
Learn MoreFrom the founder
A clinical perspective.
A strategic lens.
I founded FJScience to bring together two things rarely combined: bedside clinical understanding and senior strategic experience. Twenty-six years across drug development and medical affairs — applied with the rigour and judgement clients expect at the most critical decision timepoints.
Francisco J. Sapunar, MD
Founder
Tell us about your project.
Whether you're navigating a pivotal trial decision, a competitive launch, or an emerging access challenge — let's explore it together.